학술논문
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial
Document Type
Article
Author
Beckmann, Anna Marie; Hsu, Fan-Chi; Albertson, Sarah; Veldsman, Ashley; Schreuder, Constance; Smit, Erica; Cloete, Yolundi; Ontong, Cynthia; Filander, Elisabeth; Jacobs, Gail; Keyser, Alana; Africa, Hadn; Mulenga, Humphrey; Noble, Julia; Makhethe, Lebohang; Steyn, Marcia; de Kock, Marwou; Quaqua, Nambitha; Lu, Yiwen; Gutschmidt, Andrea; Thienemann, Friedrich; Kahn, Stuart; Mouton, Angelique; Van Rooyen, Elma; Opperman, Fajwa; Swarts, Ann; Van Schalkwyk, Amaryl; Herselman, Yolandi; Hofmeester, Devona; Amsterdam, Julia; Hassanally, Leya; van der Merwe, Linda; Companie, Alessandro; Rossouw, Susan; Jones, Carolyn; Botes, Natasja; van der Riet, Elize; Goliath, Sandra; Kruger, Sandra; Sinandile, Eunice; Day, Tracey A ; Penn-Nicholson, Adam ; Luabeya, Angelique Kany Kany; Fiore-Gartland, Andrew; Du Plessis, Nelita; Loxton, Andre G; Vergara, Julie; Rolf, Tom A; Reid, Tim D; Toefy, Asma; Shenje, Justin; Geldenhuys, Hendrik; Tameris, Michele; Mabwe, Simbarashe; Bilek, Nicole; Bekker, Linda-Gail; Diacon, Andreas; Walzl, Gerhard; Ashman, Jill; Frevol, Aude; Sagawa, Zachary K; Lindestam Arlehamn, Cecilia; Sette, Alessandro; Reed, Steven G; Coler, Rhea N; Scriba, Thomas J; Hatherill, Mark
Source
In The Lancet Respiratory Medicine April 2021 9(4):373-386
Subject
Language
ISSN
2213-2600